Alcohol use and fluoxetine
Pro Research Analysisby 
Searched over 200M research papers
Fluoxetine and Alcohol Use: Effects on Consumption and Craving
Fluoxetine Reduces Alcohol Craving and Intake in Some Populations
Research shows that fluoxetine, a selective serotonin reuptake inhibitor (SSRI), can reduce the desire to drink alcohol and, in some cases, actual alcohol consumption. In mildly to moderately dependent alcoholics, fluoxetine significantly decreased the desire, interest, and craving for alcohol compared to baseline, although the reduction in actual daily alcohol intake was modest and not statistically significant in outpatient settings. The effect was more pronounced in controlled experimental sessions, where both mean and maximum desire to drink were lower after fluoxetine than after placebo. These findings suggest fluoxetine may be more effective in reducing alcohol craving than in reducing consumption, especially in individuals not actively seeking to reduce their drinking .
Dose-Dependent Effects and Differences by Alcoholic Subtype
Higher doses of fluoxetine (60 mg/day) have been shown to decrease mean daily alcoholic drinks and total drinks over a two-week period in early-stage problem drinkers, while lower doses (40 mg/day) and placebo did not have significant effects. However, the reduction in alcohol intake was not always significantly different from placebo, and the effect did not lead to more days of abstinence. Additionally, fluoxetine increased nonalcoholic beverage consumption and cigarette smoking at higher doses .
The response to fluoxetine may also depend on the type of alcoholism. In familial alcoholic patients, fluoxetine significantly reduced alcohol intake, while in nonfamilial alcoholics, the effect was minimal. This suggests that underlying biological differences, such as monoaminergic underactivity, may influence the effectiveness of fluoxetine in reducing alcohol consumption . Conversely, in high-risk/severity (type B) alcoholics, fluoxetine treatment actually resulted in poorer drinking outcomes compared to placebo, indicating that fluoxetine may not be suitable for all subtypes of alcohol dependence, especially in the absence of comorbid mood or anxiety disorders .
Fluoxetine in Patients with Comorbid Depression and Alcohol Use Disorder
In adults with both major depressive disorder and alcohol dependence, fluoxetine was effective in reducing both depressive symptoms and alcohol consumption compared to placebo. This suggests that fluoxetine may be particularly beneficial for individuals with comorbid depression and alcohol use disorder . Similarly, in adolescents with comorbid major depression and alcohol use disorder, open-label studies found that fluoxetine reduced both depressive symptoms and drinking . However, in a double-blind, placebo-controlled trial where all participants also received cognitive behavioral therapy (CBT) and motivational enhancement therapy (MET), there was no significant difference between fluoxetine and placebo in reducing depression or alcohol use, possibly due to the strong effects of psychotherapy or limited sample size .
Further analysis indicated that adolescents with chronic depression and no more than moderate alcohol use responded better to fluoxetine than those with transient depression and heavy alcohol use, suggesting that the severity of alcohol use may moderate the antidepressant response to fluoxetine in youth .
Short-Term Versus Long-Term Effects
The reduction in alcohol intake with fluoxetine may be short-lived. In a controlled inpatient study, fluoxetine led to a 14% reduction in alcohol intake during the first week, but this effect did not persist in later weeks . This suggests that while fluoxetine may have an initial impact on reducing alcohol consumption, its long-term effectiveness may be limited without additional interventions or motivation to reduce drinking.
Neurobiological Considerations and Relapse Risk
Animal studies indicate that stopping fluoxetine treatment during abstinence can increase alcohol-seeking behavior during relapse. This effect is linked to changes in endocannabinoid and glutamatergic signaling in the central amygdala, which may facilitate alcohol drinking behavior after discontinuation of fluoxetine . These findings highlight the importance of monitoring for relapse risk when discontinuing fluoxetine in individuals with alcohol use disorder.
Conclusion
Fluoxetine can reduce alcohol craving and, in some cases, alcohol consumption, particularly in individuals with comorbid depression or certain subtypes of alcoholism. Its effectiveness varies by dose, individual characteristics, and the presence of comorbid conditions. While fluoxetine may be a useful adjunct in motivated patients or those with depression, its benefits for reducing alcohol intake alone are modest and may not persist long-term. Careful consideration of patient subtype and ongoing monitoring are important when using fluoxetine in the context of alcohol use disorders.
Sources and full results
Most relevant research papers on this topic